Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Autism | MicrobiomeTrials← Back to trialsNCT05003960
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Autism
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2022-01-23Est. Completion: 2027-12-01
Enrollment target: 15 participants Locations- Prodromos Stem Cell Institute, Naples, Florida, United States
- Prodromos Stem Cell Institute, Athens, Greece
Other microbiome trials you might be interested in
Autism Spectrum DisorderTherapy
The project aims to develop and implement the Strategies for Toddler Autism spectrum disorder(ASD) with Remote-therapy (…
Shanghai, ChinaEst. completion Dec 30, 2026
Neuropsychiatric DisorderNeurological DisorderNeurodevelopmental DisorderSleep
Background:
\- Many psychiatric, behavioral, and developmental disorders are genetic. This means that they tend to run …
Bethesda, United StatesCompleted Jul 24, 2025
Smith-Magenis SyndromeAutism Spectrum Disorder
Autism Spectrum Disorders (ASD) are a neurodevelopmental disorder. Their prevalence is estimated at around 0.4% of the g…
Bron, FranceEst. completion Apr 2027